NORTHERN TRUST CORP - AYTU BIOPHARMA INC ownership

AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 43 filers reported holding AYTU BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of AYTU BIOPHARMA INC
ValueSharesWeighting
Q4 2022$8,806
-2.2%
46,5930.0%0.00%
Q3 2022$9,000
-73.5%
46,593
-3.2%
0.00%
Q2 2022$34,000
-35.8%
48,132
-1.0%
0.00%
Q1 2022$53,000
-19.7%
48,632
-0.4%
0.00%
Q4 2021$66,000
-53.2%
48,843
-0.5%
0.00%
Q3 2021$141,000
-40.3%
49,090
+4.3%
0.00%
Q2 2021$236,000
-85.4%
47,061
-77.9%
0.00%
Q1 2021$1,620,000
+452.9%
213,140
+335.4%
0.00%
Q4 2020$293,00048,9510.00%
Other shareholders
AYTU BIOPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,379,936$2,570,0000.05%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 10,880$12,0000.00%
Renaissance Technologies 765,469$827,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 53,530$58,0000.00%
Focused Wealth Management, Inc 209$00.00%
FEDERATED HERMES, INC. 5,633$6,0000.00%
JANICZEK WEALTH MANAGEMENT, LLC 1$00.00%
UBS Group AG 1$00.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 100$00.00%
IFP Advisors, Inc 2,400$16,0000.00%
View complete list of AYTU BIOPHARMA INC shareholders